Induction of Transglutaminase 2 by a Liver X Receptor/Retinoic Acid Receptor α Pathway Increases the Clearance of Apoptotic Cells by Human Macrophages
Authors:
- Cédric RébéCRCédric Rébé
- Magalie RaveneauMRMagalie Raveneau
- Angélique ChevriauxACAngélique Chevriaux
- Daniela LakomyDLDaniela Lakomy
- Anne-Laure SbernaASAnne-Laure Sberna
- Annie CostaACAnnie Costa
- Ginette BessèdeGBGinette Bessède
- Anne AthiasAAAnne Athias
- Eric SteinmetzESEric Steinmetz
- Jean Marc A. LobaccaroJLJean Marc A. Lobaccaro
- Georges AlvesGAGeorges Alves
- Alexandre MenicacciAMAlexandre Menicacci
- 14 August 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 105 (4) , 393-401
Abstract
Rationale: Liver X receptors (LXRs) are oxysterol-activated nuclear receptors that are involved in the control of cholesterol homeostasis and inflammatory response. Human monocytes and macrophages express high levels of these receptors and are appropriate cells to study the response to LXR agonists. Objective: The purpose of this study was to identify new LXR targets in human primary monocytes and macrophages and the consequences of their activation. Methods and Results: We show that LXR agonists significantly increase the mRNA and protein levels of the retinoic acid receptor (RAR)α in primary monocytes and macrophages. LXR agonists promote RARα gene transcription through binding to a specific LXR response element on RARα gene promoter. Preincubation of monocytes or macrophages with LXR agonists before RARα agonist treatment enhances synergistically the expression of several RARα target genes. One of these genes encodes transglutaminase (TGM)2, a key factor required for macrophage phagocytosis. Accordingly, the combination of LXR and RARα agonists at concentrations found in human atherosclerotic plaques markedly enhances the capabilities of macrophages to engulf apoptotic cells in a TGM2-dependent manner. Conclusions: These results indicate an important role for LXRs in the control of phagocytosis through an RARα-TGM2–dependent mechanism. A combination of LXR/RARα agonists that may operate in atherosclerosis could also constitute a promising strategy to improve the clearance of apoptotic cells by macrophages in other pathological situations.Keywords
This publication has 40 references indexed in Scilit:
- The Nuclear Receptor Rev-erbα Is a Liver X Receptor (LXR) Target Gene Driving a Negative Feedback Loop on Select LXR-Induced Pathways in Human MacrophagesMolecular Endocrinology, 2008
- LIVER X RECEPTOR IS A KEY REGULATOR OF CYTOKINE RELEASE IN HUMAN MONOCYTESShock, 2008
- Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human MacrophagesCirculation Research, 2007
- PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cellsJournal of Experimental Medicine, 2006
- Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolitesThe EMBO Journal, 2006
- Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human MacrophagesJournal of Biological Chemistry, 2002
- Molecular Characterization and Developmental Expression ofNORPEG, a Novel Gene Induced by Retinoic AcidJournal of Biological Chemistry, 2001
- Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X ReceptorJournal of Biological Chemistry, 2000
- Evidence for the Involvement of Retinoic Acid Receptor RARα-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by RetinoidsJournal of Biological Chemistry, 1995
- Induction of tissue transglutaminase in human peripheral blood monocytes.Journal of Experimental Medicine, 1984